Last CNY23.29 CNY
Change Today -0.98 / -4.04%
Volume 89.4M
600518 On Other Exchanges
As of 2:05 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

kangmei pharmaceutical co-a (600518) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/2/15 - CNY24.78
52 Week Low
07/18/14 - CNY13.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KANGMEI PHARMACEUTICAL CO-A (600518)

Related News

No related news articles were found.

kangmei pharmaceutical co-a (600518) Related Businessweek News

No Related Businessweek News Found

kangmei pharmaceutical co-a (600518) Details

Kangmei Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and medical devices primarily in China. The company's principal products include Chinese medicines, such as American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica, lonicera flower, and others. Its products also comprise chemical drugs consisting of clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, paracetamol and pseudoephedrine hydrochloride tablets, and others. In addition, the company is involved in the wholesale and retail of other medical materials, such as bird's nest, ganoderma, sea horse, isinglass, forest frog, and others. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Puning, China.

Founded in 1997

kangmei pharmaceutical co-a (600518) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kangmei pharmaceutical co-a (600518) Key Developments

Kangmei Pharmaceutical Co., Ltd. Approves Proposal to Invest RMB 1 Billion in Constructing China - Asean Kangmei Yulin Herbs Industry Park Project

Kangmei Pharmaceutical Co., Ltd. held the first special shareholders' meeting of 2015 on January 30, 2015, which discussed and approved the proposal of planning to invest RMB 1 billion in constructing China - ASEAN Kangmei Yulin Herbs Industry Park Project and the proposal of changing business scope.

Kangmei Pharmaceutical Co., Ltd. to Build TCM Industrial Park in Guangxi

Kangmei Pharmaceutical Co., Ltd. announced that its board of directors agreed it to invest CNY 1 billion to build China ASEAN Kangmei traditional Chinese medicine (TCM) industrial park in Yulin City, Guangxi and set up a wholly-owned subsidiary to be responsible for the project's construction and operation. The project plans to use a land area of about 500 mu (1 mu = 667 square meters) and will build a standard TCM slice production base, TCM materials processing and purification base, modern storage and logistics and ancillary facilities, etc. The planned total investment is CNY 1 billion, the initially planned construction period is four years and annual production capacity will be above 300,000 tons of TCM after the project reaching full production.

Kangmei Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jan 30, 2015

Kangmei Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jan 30, 2015. Agenda: To discuss the planning to convert to invest RMB 1 billion in constructing China - ASEAN Kangmei Yulin Herbs Industry Park project; and to consider changing of business scope.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600518:CH CNY23.29 CNY -0.98

600518 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600518.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600518 Industry Range
Price/Earnings 26.2x
Price/Sales 3.4x
Price/Book 4.0x
Price/Cash Flow 26.2x
TEV/Sales 2.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KANGMEI PHARMACEUTICAL CO-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at